Repeated adverse fetal outcome in pregnancy complicated by uncontrolled maternal phenylketonuria

Journal of Paediatrics and Child Health

Volumn 35, Issue 5, 1999, Pages 499-502

  Kesby, G J ^a  

^a Sydney Obstet/Gynaecol Ultrasound   (Australia)

Author keywords

Diet; Fetal; Hyperphenylalaninemia; Pregnancy

Indexed keywords

PHENYLALANINE;

ARTICLE; COGNITIVE DEFECT; CONGENITAL HEART DISEASE; DIET THERAPY; FEMALE; FETUS; FETUS DISEASE; FETUS OUTCOME; GROWTH DISORDER; HUMAN; HYPERPHENYLALANINEMIA; LOW BIRTH WEIGHT; MICROCEPHALY; PHENYLKETONURIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ADULT; FEMALE; FETAL DISEASES; HUMANS; MENTAL RETARDATION; PHENYLALANINE; PHENYLKETONURIA, MATERNAL; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SYNDROME;

EID: 0032843670     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.1999.355370.x     Document Type: Article

References (14)

1. Dent CE. In discussion of Armstrong MD. Relation of biochemical abnormality to development of mental defect in phenylketonuria. In Etiologic Factors in Mental Retardation, Report of the 23rd Ross Pediatric Research Conference 1956. Ross Laboratories, Columbus, Ohio, 1957; 32-33.
2. Yu JS, O'Halloran MT. Children of mothers with phenylketonuria. Lancet 1970; 1: 210-2.
3. Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia. N. Engl. J. Med. 1980; 303: 1202-8.
4. Levy HL, Waisbren S. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus. N. Engl. J. Med. 1983; 309: 1269-74.
5. Lipson A, Beuhler B, Bartley J et al. Maternal hyperphenylalaninemia: Fetal effects. J. Pediatr. 1984; 104: 16-20.
6. Levy HL, Lobbregt D, Sansaricq C, Snyderman SE. Comparison of phenylketonuric and nonphenylketonuric sibs from untreated pregnancies in a mother with phenylketonuria. Am. J. Med. Genet. 1992; 44: 439-42.
7. Michals K, Acosta PB, Austin V et al. Nutrition and reproductive outcome in maternal phenylketonuria. Eur. J. Pediatr. 1996; 155 (Suppl. 1): S165-S168.
8. Koch R, Levy H, Hanley W, Matalon R, Rouse B, de Trefz F, la Cruz F. Outcome implications of the international Maternal Phenylketonuria Collaborative Study (MPKUCS): 1994. Eur. J. Pediatr. 1996; 155 (Suppl. 1): S 162-164.
9. Burgard P, Rupp A, Konecki DS, Trefz FK, Schmidt H, Lichter-Konecki U. Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria. Eur. J. Pediatr. 1996; 155 (Suppl.): S11-S15.
10. Kecskemethy HH, Lobbregt D, Levy HL. The use of gelatin capsules for ingestion of formula in dietary treatment of maternal phenylketonuria. J. Inherit. Metab. Dis. 1993; 16: 111-8.
11. Matalon R, Michals K, Gleason L. Maternal PKU strategies for dietary treatment and monitoring compliance. Ann. NY Acad. Sci. 1986; 477: 223-30.
12. Paton vs British Pregnancy Advisory Service Trustees. QB 1979; 276.
13. Special Project 1986. Legal rights and issues surrounding conception, pregnancy, and birth, 'maternal rights vs fetal rights' 39. Vanderbilt Law Rev. 1986; 819: 835-6.
14. People vs Pointer, California Reporter 1984; 199: 357.